The Vall d'Hebron University Hospital's CEIm aims to decisively contribute to improving the quality, management and relevancy of clinical trials that are to be carried out in our environment. This positioning makes clear the desire to strengthen the positioning of the Hospital and its CEIm, not only in terms of being more competitive in the research market, but also developing and exercising leadership in the promotion of research that aims to solve clinical problems.

The ethical-methodological evaluation of clinical trial protocols and research projects corresponds to the Hospital's CEIm. The European and Spanish regulations on clinical trials require intense development of the capacities and functions of CEIms, especially with regard to multicentre trials. Similarly, the development of the regulations requires that post-authorisation observational studies be evaluated by the CEIm.

The Ethics Committees Support Unit (USCE) aims to improve the quality and efficiency of the actions of the Ethics Committee for Research with Medicines (CEIM) and the Animal Experimentation Committee (CEEA) of the Vall d'Hebron University Hospital, in accordance with current Catalan, Spanish and European legislation.

Do you want to know all the actions it carries out?

The Clinical Research Ethics Committee (CEIm) at the Vall d'Hebron University Hospital was created on 26 October 1992 (Department of Health and Social Security Order 26.10.1992) to enforce Law 25/1990, dated 20 December, regarding drugs.

This law establishes the need for all clinical trial projects with drugs and medical devices to be previously approved by a clinical research ethics committee, which will have to be accredited by the competent authority, which, in the case of Catalonia , is the Department of Health and Social Security of the Generalitat of Catalonia.